Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2017

Open Access 01-12-2017 | Research article

Pigment Epithelium-Derived Factor (PEDF) mediates cartilage matrix loss in an age-dependent manner under inflammatory conditions

Authors: Daisy S. Nakamura, Judith M. Hollander, Tomoya Uchimura, Heber C. Nielsen, Li Zeng

Published in: BMC Musculoskeletal Disorders | Issue 1/2017

Login to get access

Abstract

Background

Inflammation is a major cause of cartilage destruction and leads to the imbalance of metabolic activities in the arthritic joint. Pigment epithelium-derived factor (PEDF) has been reported to have both pro- and anti-inflammatory activities in various cell types and to be upregulated in the arthritic joint, but its role in joint destruction is unclear. Our aim was to investigate the role of PEDF in cartilage degeneration under inflammatory conditions.

Methods

PEDF was ectopically expressed in primary human articular chondrocytes, and catabolic gene expression and protein secretion in response to the pro-inflammatory cytokine interleukin 1 beta (IL-1β) were evaluated. Metatarsal bones from PEDF-deficient and wild type mice were cultured in the presence or absence of IL-1β. Cartilage matrix integrity and matrix metalloproteinases MMP-1, MMP-3, and MMP-13 were evaluated. PEDF-deficient and wild type mice were evaluated in the monosodium iodoacetate (MIA) inflammatory joint destruction animal model to determine the role of PEDF in inflammatory arthritis in vivo. Student’s t-tests and Mann–Whitney tests were employed where appropriate, for parametric and non-parametric data, respectively.

Results

We showed that PEDF protein levels were higher in human osteoarthritis samples compared to normal samples. We demonstrated that ectopic PEDF expression in primary human articular chondrocytes exacerbated catabolic gene expression in the presence of IL-1β. In whole bone organ cultures, IL-1β induced MMP-1, MMP-3 and MMP-13 protein production, and caused significant cartilage matrix loss. Interestingly, Toluidine Blue staining showed that PEDF-deficient bones from 29 week old animals, but not 10 week old animals, had reduced matrix loss in response to IL-1β compared to their wild type counterparts. In addition, PEDF-deficiency in 29 week old animals preserved matrix integrity and protected against cell loss in the MIA joint destruction model in vivo.

Conclusion

We conclude that PEDF exacerbates cartilage degeneration in an age-dependent manner under an inflammatory setting. This is the first study identifying a specific role for PEDF in joint inflammation and highlights the multi-faceted activities of PEDF.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hootman JM, et al. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015–2040. Arthritis Rheumatol. 2016;68(7):1582–7.CrossRefPubMed Hootman JM, et al. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015–2040. Arthritis Rheumatol. 2016;68(7):1582–7.CrossRefPubMed
3.
go back to reference Joosten LA, et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol. 1999;163(9):5049–55.PubMed Joosten LA, et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol. 1999;163(9):5049–55.PubMed
4.
go back to reference Joosten LA, et al. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum. 1996;39(5):797–809.CrossRefPubMed Joosten LA, et al. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum. 1996;39(5):797–809.CrossRefPubMed
5.
go back to reference Palmer G, et al. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis. Eur J Immunol. 2003;33(2):434–40.CrossRefPubMed Palmer G, et al. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis. Eur J Immunol. 2003;33(2):434–40.CrossRefPubMed
6.
go back to reference Furman BD, et al. Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis. Arthritis Res Ther. 2014;16(3):R134.CrossRefPubMedPubMedCentral Furman BD, et al. Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis. Arthritis Res Ther. 2014;16(3):R134.CrossRefPubMedPubMedCentral
7.
go back to reference Fan Z, et al. Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1beta. Arthritis Rheum. 2005;52(1):136–43.CrossRefPubMed Fan Z, et al. Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1beta. Arthritis Rheum. 2005;52(1):136–43.CrossRefPubMed
8.
go back to reference Mengshol JA, et al. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43(4):801–11.CrossRefPubMed Mengshol JA, et al. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43(4):801–11.CrossRefPubMed
9.
go back to reference Reboul P, et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest. 1996;97(9):2011–9.CrossRefPubMedPubMedCentral Reboul P, et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest. 1996;97(9):2011–9.CrossRefPubMedPubMedCentral
10.
go back to reference Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001;44(3):585–94.CrossRefPubMed Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001;44(3):585–94.CrossRefPubMed
11.
go back to reference Little CB, et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum. 2009;60(12):3723–33.CrossRefPubMedPubMedCentral Little CB, et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum. 2009;60(12):3723–33.CrossRefPubMedPubMedCentral
12.
go back to reference Chevalier X, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2009;61(3):344–52.CrossRefPubMed Chevalier X, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2009;61(3):344–52.CrossRefPubMed
13.
go back to reference Cohen SB, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther. 2011;13(4):R125.CrossRefPubMedPubMedCentral Cohen SB, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther. 2011;13(4):R125.CrossRefPubMedPubMedCentral
14.
go back to reference Bresnihan B, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998;41(12):2196–204.CrossRefPubMed Bresnihan B, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998;41(12):2196–204.CrossRefPubMed
15.
go back to reference Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 1991;53(3):411–4.CrossRefPubMed Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 1991;53(3):411–4.CrossRefPubMed
16.
go back to reference Steele FR, et al. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A. 1993;90(4):1526–30.CrossRefPubMedPubMedCentral Steele FR, et al. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A. 1993;90(4):1526–30.CrossRefPubMedPubMedCentral
17.
go back to reference Quan GM, et al. Localization of pigment epithelium-derived factor in growing mouse bone. Calcif Tissue Int. 2005;76(2):146–53.CrossRefPubMed Quan GM, et al. Localization of pigment epithelium-derived factor in growing mouse bone. Calcif Tissue Int. 2005;76(2):146–53.CrossRefPubMed
18.
go back to reference He X, et al. PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases. Clin Sci (Lond). 2015;128(11):805–23.CrossRef He X, et al. PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases. Clin Sci (Lond). 2015;128(11):805–23.CrossRef
19.
go back to reference Chetty A, et al. Pigment epithelium-derived factor mediates impaired lung vascular development in neonatal hyperoxia. Am J Respir Cell Mol Biol. 2015;52(3):295–303.CrossRefPubMedPubMedCentral Chetty A, et al. Pigment epithelium-derived factor mediates impaired lung vascular development in neonatal hyperoxia. Am J Respir Cell Mol Biol. 2015;52(3):295–303.CrossRefPubMedPubMedCentral
20.
go back to reference Hoshina D, et al. The role of PEDF in tumor growth and metastasis. Curr Mol Med. 2010;10(3):292–5.CrossRefPubMed Hoshina D, et al. The role of PEDF in tumor growth and metastasis. Curr Mol Med. 2010;10(3):292–5.CrossRefPubMed
21.
go back to reference Manalo KB, et al. Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective. Expert Opin Ther Pat. 2011;21(2):121–30.CrossRefPubMedPubMedCentral Manalo KB, et al. Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective. Expert Opin Ther Pat. 2011;21(2):121–30.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Rychli K, Huber K, Wojta J. Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease. Expert Opin Ther Targets. 2009;13(11):1295–302.CrossRefPubMed Rychli K, Huber K, Wojta J. Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease. Expert Opin Ther Targets. 2009;13(11):1295–302.CrossRefPubMed
24.
go back to reference Liu JT, et al. Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol. 2012;2012:871272.PubMedPubMedCentral Liu JT, et al. Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol. 2012;2012:871272.PubMedPubMedCentral
25.
go back to reference Yabe T, Sanagi T, Yamada H. The neuroprotective role of PEDF: implication for the therapy of neurological disorders. Curr Mol Med. 2010;10(3):259–66.CrossRefPubMed Yabe T, Sanagi T, Yamada H. The neuroprotective role of PEDF: implication for the therapy of neurological disorders. Curr Mol Med. 2010;10(3):259–66.CrossRefPubMed
26.
go back to reference Zhang SX, et al. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J. 2006;20(2):323–5.PubMed Zhang SX, et al. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J. 2006;20(2):323–5.PubMed
27.
go back to reference Wang JJ, et al. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am J Physiol Renal Physiol. 2008;294(5):F1166–73.CrossRefPubMed Wang JJ, et al. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am J Physiol Renal Physiol. 2008;294(5):F1166–73.CrossRefPubMed
28.
go back to reference Famulla S, et al. Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int J Obes (Lond). 2011;35(6):762–72.CrossRef Famulla S, et al. Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int J Obes (Lond). 2011;35(6):762–72.CrossRef
29.
go back to reference Yabe T, et al. Pigment epithelium-derived factor induces pro-inflammatory genes in neonatal astrocytes through activation of NF-kappa B and CREB. Glia. 2005;50(3):223–34.CrossRefPubMed Yabe T, et al. Pigment epithelium-derived factor induces pro-inflammatory genes in neonatal astrocytes through activation of NF-kappa B and CREB. Glia. 2005;50(3):223–34.CrossRefPubMed
30.
go back to reference Pfander D, et al. Pigment epithelium derived factor--the product of the EPC-1 gene--is expressed by articular chondrocytes and up regulated in osteoarthritis. Ann Rheum Dis. 2006;65(7):965–7.CrossRefPubMedPubMedCentral Pfander D, et al. Pigment epithelium derived factor--the product of the EPC-1 gene--is expressed by articular chondrocytes and up regulated in osteoarthritis. Ann Rheum Dis. 2006;65(7):965–7.CrossRefPubMedPubMedCentral
31.
go back to reference Klinger P, et al. The transient chondrocyte phenotype in human osteophytic cartilage: a role of pigment epithelium-derived factor? Cartilage. 2013;4(3):249–55.CrossRefPubMedPubMedCentral Klinger P, et al. The transient chondrocyte phenotype in human osteophytic cartilage: a role of pigment epithelium-derived factor? Cartilage. 2013;4(3):249–55.CrossRefPubMedPubMedCentral
32.
go back to reference van der Sluijs JA, et al. The reliability of the Mankin score for osteoarthritis. J Orthop Res. 1992;10(1):58–61.CrossRefPubMed van der Sluijs JA, et al. The reliability of the Mankin score for osteoarthritis. J Orthop Res. 1992;10(1):58–61.CrossRefPubMed
33.
go back to reference Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.CrossRefPubMed Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.CrossRefPubMed
34.
go back to reference Huang Q, et al. PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. Exp Eye Res. 2008;87(3):226–41.CrossRefPubMedPubMedCentral Huang Q, et al. PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. Exp Eye Res. 2008;87(3):226–41.CrossRefPubMedPubMedCentral
36.
go back to reference Shin ES, Sorenson CM, Sheibani N. PEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium. Am J Physiol Lung Cell Mol Physiol. 2014;306(7):L620–34.CrossRefPubMed Shin ES, Sorenson CM, Sheibani N. PEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium. Am J Physiol Lung Cell Mol Physiol. 2014;306(7):L620–34.CrossRefPubMed
37.
go back to reference Wiegand SJ, et al. Genetic modulation of pigment epithelium–derived factor (PEDF) expression does not alter normal or pathological angiogenesis in the eye, or tumor growth, in The Association for Research in Vision and Ophthalmology. 2004. Wiegand SJ, et al. Genetic modulation of pigment epithelium–derived factor (PEDF) expression does not alter normal or pathological angiogenesis in the eye, or tumor growth, in The Association for Research in Vision and Ophthalmology. 2004.
38.
go back to reference Renard RA, et al. Eye Phenotype of Pigment Epithelium-Derived Factor Knockout Mice, in The Association for Research in Vision and Ophthalmology. 2003. Renard RA, et al. Eye Phenotype of Pigment Epithelium-Derived Factor Knockout Mice, in The Association for Research in Vision and Ophthalmology. 2003.
39.
go back to reference Glasson SS, et al. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010;18 Suppl 3:S17–23.CrossRefPubMed Glasson SS, et al. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010;18 Suppl 3:S17–23.CrossRefPubMed
40.
go back to reference Uchimura T, et al. The Chondroprotective Role of Erythromycin in a Murine Joint Destruction Model. Cartilage. 2016 Uchimura T, et al. The Chondroprotective Role of Erythromycin in a Murine Joint Destruction Model. Cartilage. 2016
41.
go back to reference Anguissola S, et al. Pigment epithelium-derived factor (PEDF) interacts with transportin SR2, and active nuclear import is facilitated by a novel nuclear localization motif. PLoS One. 2011;6(10):e26234.CrossRefPubMedPubMedCentral Anguissola S, et al. Pigment epithelium-derived factor (PEDF) interacts with transportin SR2, and active nuclear import is facilitated by a novel nuclear localization motif. PLoS One. 2011;6(10):e26234.CrossRefPubMedPubMedCentral
42.
go back to reference Tombran-Tink J, Johnson LV. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci. 1989;30(8):1700–7.PubMed Tombran-Tink J, Johnson LV. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci. 1989;30(8):1700–7.PubMed
43.
go back to reference Tombran-Tink J, et al. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci. 1995;15(7 Pt 1):4992–5003.PubMed Tombran-Tink J, et al. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci. 1995;15(7 Pt 1):4992–5003.PubMed
44.
go back to reference Sawant S, et al. Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem Biophys Res Commun. 2004;325(2):408–13.CrossRefPubMed Sawant S, et al. Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem Biophys Res Commun. 2004;325(2):408–13.CrossRefPubMed
45.
go back to reference Karakousis PC, et al. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol Vis. 2001;7:154–63.PubMed Karakousis PC, et al. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol Vis. 2001;7:154–63.PubMed
46.
go back to reference Tombran-Tink J, et al. PEDF and the serpins: phylogeny, sequence conservation, and functional domains. J Struct Biol. 2005;151(2):130–50.CrossRefPubMed Tombran-Tink J, et al. PEDF and the serpins: phylogeny, sequence conservation, and functional domains. J Struct Biol. 2005;151(2):130–50.CrossRefPubMed
47.
go back to reference van der Sluijs JA, Thesingh CW, Scherft JP. Skin inhibits cartilage proliferation and calcification. Tissue culture of fetal mice bones. Acta Orthop Scand. 1986;57(6):518–22.CrossRefPubMed van der Sluijs JA, Thesingh CW, Scherft JP. Skin inhibits cartilage proliferation and calcification. Tissue culture of fetal mice bones. Acta Orthop Scand. 1986;57(6):518–22.CrossRefPubMed
48.
go back to reference Klement BJ, Spooner BS. Embryonic mouse pre-metatarsal development in organ culture. J Exp Zool. 1993;265(3):285–94.CrossRefPubMed Klement BJ, Spooner BS. Embryonic mouse pre-metatarsal development in organ culture. J Exp Zool. 1993;265(3):285–94.CrossRefPubMed
49.
go back to reference Song W, et al. The fetal mouse metatarsal bone explant as a model of angiogenesis. Nat Protoc. 2015;10(10):1459–73.CrossRefPubMed Song W, et al. The fetal mouse metatarsal bone explant as a model of angiogenesis. Nat Protoc. 2015;10(10):1459–73.CrossRefPubMed
50.
go back to reference Landman EB, et al. Small molecule inhibitors of WNT/beta-catenin signaling block IL-1beta- and TNFalpha-induced cartilage degradation. Arthritis Res Ther. 2013;15(4):R93.CrossRefPubMedPubMedCentral Landman EB, et al. Small molecule inhibitors of WNT/beta-catenin signaling block IL-1beta- and TNFalpha-induced cartilage degradation. Arthritis Res Ther. 2013;15(4):R93.CrossRefPubMedPubMedCentral
51.
go back to reference Alberdi E, Hyde CC, Becerra SP. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry. 1998;37(30):10643–52.CrossRefPubMed Alberdi E, Hyde CC, Becerra SP. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry. 1998;37(30):10643–52.CrossRefPubMed
52.
go back to reference Meyer C, Notari L, Becerra SP. Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J Biol Chem. 2002;277(47):45400–7.CrossRefPubMed Meyer C, Notari L, Becerra SP. Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J Biol Chem. 2002;277(47):45400–7.CrossRefPubMed
53.
54.
go back to reference Loeser RF, et al. Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum. 2012;64(3):705–17.CrossRefPubMedPubMedCentral Loeser RF, et al. Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum. 2012;64(3):705–17.CrossRefPubMedPubMedCentral
55.
go back to reference Barve RA, et al. Transcriptional profiling and pathway analysis of monosodium iodoacetate-induced experimental osteoarthritis in rats: relevance to human disease. Osteoarthritis Cartilage. 2007;15(10):1190–8.CrossRefPubMed Barve RA, et al. Transcriptional profiling and pathway analysis of monosodium iodoacetate-induced experimental osteoarthritis in rats: relevance to human disease. Osteoarthritis Cartilage. 2007;15(10):1190–8.CrossRefPubMed
56.
go back to reference Guzman RE, et al. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol. 2003;31(6):619–24.CrossRefPubMed Guzman RE, et al. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol. 2003;31(6):619–24.CrossRefPubMed
57.
go back to reference Guingamp C, et al. Mono-iodoacetate-induced experimental osteoarthritis: a dose–response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 1997;40(9):1670–9.CrossRefPubMed Guingamp C, et al. Mono-iodoacetate-induced experimental osteoarthritis: a dose–response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 1997;40(9):1670–9.CrossRefPubMed
58.
go back to reference Akiyama T, et al. PEDF regulates osteoclasts via osteoprotegerin and RANKL. Biochem Biophys Res Commun. 2010;391(1):789–94.CrossRefPubMed Akiyama T, et al. PEDF regulates osteoclasts via osteoprotegerin and RANKL. Biochem Biophys Res Commun. 2010;391(1):789–94.CrossRefPubMed
59.
go back to reference Gattu AK, et al. Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J. 2013;27(11):4384–94.CrossRefPubMedPubMedCentral Gattu AK, et al. Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J. 2013;27(11):4384–94.CrossRefPubMedPubMedCentral
60.
go back to reference Li F, et al. Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cells. 2013;31(12):2714–23.CrossRefPubMed Li F, et al. Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cells. 2013;31(12):2714–23.CrossRefPubMed
61.
go back to reference Karp SJ, et al. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development. 2000;127(3):543–8.PubMed Karp SJ, et al. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development. 2000;127(3):543–8.PubMed
62.
go back to reference Kempf H, et al. Prochondrogenic signals induce a competence for Runx2 to activate hypertrophic chondrocyte gene expression. Dev Dyn. 2007;236(7):1954–62.CrossRefPubMed Kempf H, et al. Prochondrogenic signals induce a competence for Runx2 to activate hypertrophic chondrocyte gene expression. Dev Dyn. 2007;236(7):1954–62.CrossRefPubMed
63.
go back to reference Frank MG, et al. Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav Immun. 2012;26(2):337–45.CrossRefPubMed Frank MG, et al. Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav Immun. 2012;26(2):337–45.CrossRefPubMed
64.
go back to reference Hoth JJ, et al. Complement mediates a primed inflammatory response after traumatic lung injury. J Trauma Acute Care Surg. 2014;76(3):601–8. discussion 608–9.CrossRefPubMedPubMedCentral Hoth JJ, et al. Complement mediates a primed inflammatory response after traumatic lung injury. J Trauma Acute Care Surg. 2014;76(3):601–8. discussion 608–9.CrossRefPubMedPubMedCentral
65.
go back to reference Loeser RF, et al. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1. Arthritis Rheumatol. 2014;66(8):2201–9.CrossRefPubMedPubMedCentral Loeser RF, et al. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1. Arthritis Rheumatol. 2014;66(8):2201–9.CrossRefPubMedPubMedCentral
66.
go back to reference Loeser RF, et al. Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum. 2000;43(9):2110–20.CrossRefPubMed Loeser RF, et al. Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum. 2000;43(9):2110–20.CrossRefPubMed
67.
go back to reference Martin JA, Ellerbroek SM, Buckwalter JA. Age-related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins. J Orthop Res. 1997;15(4):491–8.CrossRefPubMed Martin JA, Ellerbroek SM, Buckwalter JA. Age-related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins. J Orthop Res. 1997;15(4):491–8.CrossRefPubMed
69.
go back to reference Francis MK, et al. Loss of EPC-1/PEDF expression during skin aging in vivo. J Invest Dermatol. 2004;122(5):1096–105.CrossRefPubMed Francis MK, et al. Loss of EPC-1/PEDF expression during skin aging in vivo. J Invest Dermatol. 2004;122(5):1096–105.CrossRefPubMed
70.
go back to reference Steinle JJ, Sharma S, Chin VC. Normal aging involves altered expression of growth factors in the rat choroid. J Gerontol A Biol Sci Med Sci. 2008;63(2):135–40.CrossRefPubMed Steinle JJ, Sharma S, Chin VC. Normal aging involves altered expression of growth factors in the rat choroid. J Gerontol A Biol Sci Med Sci. 2008;63(2):135–40.CrossRefPubMed
71.
go back to reference Pina AL, et al. Expression of pigment-epithelium-derived factor during kidney development and aging. Cell Tissue Res. 2007;329(2):329–38.CrossRefPubMed Pina AL, et al. Expression of pigment-epithelium-derived factor during kidney development and aging. Cell Tissue Res. 2007;329(2):329–38.CrossRefPubMed
72.
go back to reference Notari L, et al. Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. J Biol Chem. 2006;281(49):38022–37.CrossRefPubMed Notari L, et al. Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. J Biol Chem. 2006;281(49):38022–37.CrossRefPubMed
73.
go back to reference Bernard A, et al. Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. J Biol Chem. 2009;284(16):10480–90.CrossRefPubMedPubMedCentral Bernard A, et al. Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. J Biol Chem. 2009;284(16):10480–90.CrossRefPubMedPubMedCentral
Metadata
Title
Pigment Epithelium-Derived Factor (PEDF) mediates cartilage matrix loss in an age-dependent manner under inflammatory conditions
Authors
Daisy S. Nakamura
Judith M. Hollander
Tomoya Uchimura
Heber C. Nielsen
Li Zeng
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2017
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-017-1410-y

Other articles of this Issue 1/2017

BMC Musculoskeletal Disorders 1/2017 Go to the issue